Cell wall active antifungal agents
- 1 November 2001
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 11 (11) , 1761-1772
- https://doi.org/10.1517/13543776.11.11.1761
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Update on antifungals targeted to the cell wall: focus on β-1,3-glucan synthase inhibitorsExpert Opinion on Investigational Drugs, 2001
- An expedient synthesis of the amide analog of the potent antifungal lipopeptidolactone FR901469Tetrahedron Letters, 2001
- Site-specific Structural Transformation of the Novel Antifungal Cycle Depsipeptide FR901469. Synthesis and Biological Activity of FR203903.The Journal of Antibiotics, 2001
- Efficacy of FK463, a (1,3)-β- d -Glucan Synthase Inhibitor, in Disseminated Azole-Resistant Candida albicans Infection in MiceAntimicrobial Agents and Chemotherapy, 2000
- Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase InhibitorsAntimicrobial Agents and Chemotherapy, 2000
- Lipid Formulations of AmphotericinJournal of Liposome Research, 1998
- Update on Invasive CandidiasisPublished by Elsevier ,1996
- Amino- and aminomethylcholesterol derivatives with fungicidal acitivityFEMS Microbiology Letters, 1994
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Papulacandin, a new antibiotic, active especially against yeastsCellular and Molecular Life Sciences, 1977